Document:

RESTRICTIVE COVENANT AGREEMENT

 

This Restrictive Covenant
Agreement (this “Agreement”) is entered into and shall be deemed effective as of the “Closing,” as
that term is defined in the Stock Exchange Agreement dated March 1, 2017 (the “SEA”) between American Housing Income
Trust, Inc., a Maryland corporation (“AHIT”) with a mailing address for notice purposes of 34225 North 27th
Drive, Building 5, Suite 238 in Phoenix, Arizona 85085, and IX Biotechnology, Inc., a Wyoming corporation (“IXB”) with
a mailing address for notice purposes of 18662 MacAurthur Blvd., Suite 200 in Irvine, California, 92612. This Agreement is by and
between AHIT, and IXB, and its respective control persons, affiliates, directors, officers and agents, including but not limited
to Michael Ogburn, Joaquin Flores and Brian Werner, and their respective assigns, heirs or designees (collectively, the “IXB
Persons” or individually, an/the “IXB Person”).

 

WHEREAS, the execution
of this Agreement is a condition precedent to performance by AHIT of the SEA pursuant to Section 5.3(7) of the SEA.

 

WHEREAS, in consideration
of the issuance of shares of restricted common stock to IXB shareholders on a pro rata basis under the SEA, IXB has agreed to contribute
to AHIT to be operated under a wholly-owned subsidiary post-closing, amongst other things, assets, resources, business relationships,
business opportunities, leases, contractual rights and other tangible and intangible assets in furtherance of cannabidol-related
biotechnology.

 

WHEREAS, the IXB Persons,
or their subsequent assigns or designees, will be members of the Board of Directors of AHIT after the closing of the SEA, and in
the case of Mr. Ogburn, will be the Chief Executive Officer and Chief Financial Officer of AHIT. Following the closing of the SEA,
Sean Zarinegar, Kenneth Hedrick and Les Gutierrez will oversee the Real Estate Committee of the Board of Directors (the “Real
Estate Committee”).

 

WHEREAS, in order to protect
against the dissipation or disposition of assets contributed by IXB related to cannabidol-related biotechnology, or cannabidol-related
biotechnology assets procured by IXB through the actions of the IXB Persons, as members of the Board of Directors post-closing
of the SEA, IXB and the IXB Persons have agreed to this Agreement.

 

WHEREAS, each party agrees
that they have had an opportunity to participate in the drafting, preparation and negotiation of this Agreement. Each party expressly
acknowledges such participation and negotiation in order to avoid the application of any rule construing contractual language against
the drafter thereof. The parties acknowledge that Paesano Akkashian Apkarian, P.C. (“PAA”) has disclosed to it that
it is legal counsel to AHIT, and that it does not represent IXB or the IXB Persons in connection with this Agreement. To the extent
any conflict of interest exists under the Michigan Rules of Professional Conduct in PAA’s representation of AHIT, IXB waives
the conflict. Furthermore, IXB acknowledges that although it has gathered information from AHIT in evaluating this Agreement, it
has relied solely on its own review, and the review of its attorneys, accountants and advisors.

    	-1- 

    	 

    

 

WHEREAS, these recitals
are not mere statements, but rather material representations relied upon by the parties in entering into this Agreement.

 

NOW, THEREFORE, for valuable
consideration, the receipt of which is acknowledged:

 

1. Representations of
IXB and the IXB Persons. IXB and the IXB Persons, collectively and individually, represent and warrant to AHIT as follows:

 

(a) As part of
the IXB Persons’ appointment to the Board of Directors of AHIT, they are expected to make new contributions of value to AHIT
in furtherance of the acquisition, management and deployment of resources in cannabidol-related biotechnology.

 

(b) The IXB Persons’
appointment creates a relationship of confidence and trust between IXB and AHIT, and with each of them with respect to any information
applicable to the business of IXB or AHIT, including but not limited to cannabidol-related biotechnology; or applicable to the
business of any client or customer of IXB or AHIT which is made known to them, individually and collectively, by IXB or AHIT, or
by any client or customer of IXB or AHIT.

 

(c) IXB and AHIT
possesses and will continue to possess after the closing of the SEA confidential information that has been created, discovered,
or developed by, or has otherwise become known to, IXB and/or AHIT, including without limitation, information created, discovered,
or developed by, or made known to IXB and the IXB Persons, and/or in which the property rights have been assigned or otherwise
conveyed by IXB to AHIT, which information relates to the present or future business of AHIT and IXB (“Proprietary Information”).
By way of illustration but not limitation, “Proprietary Information” includes trade secrets, processes, formulae, data
and know-how, improvements, inventions, techniques, marketing plans, computer software strategies, forecasts, and customer lists
related to either the property assets managed exclusively by the Real Estate Committee, or the cannabidol-related biotechnology
assets of IXB.

 

(d) The IXB Persons
represent, collectively and individually, that their performance of all the terms of this Agreement do not and will not breach
any prior or current agreements or understandings, whether written or oral, to keep in confidence proprietary information acquired
by the IXB Persons prior to the closing of the SEA and before the IXB Person’s association with IXB or AHIT. The IXB Person
has not entered into, nor will enter into, any agreement or understanding either written or oral, in conflict herewith.

 

2. Voting Agreement.
IXB and the IXB Persons agree that, post-closing of the SEA, they will vote their controlling interest in IXB or AHIT, and their
controlling interest in the Board of Directors in AHIT, to preserve all cannabidol-related biotechnology assets of IXB, including
but not limited to, agreeing to amend the Bylaws and Articles of Incorporation of AHIT requiring (a) “super-majority”
vote of shareholders, defined as approval of 66% of the issued and outstanding shares entitled to vote on any measure related to
the transfer, sale or disposition of cannabidol-related biotechnology, and or real and personal property titled to AHIT or IXB,
as a wholly-owned subsidiary of AHIT, related to the development of cannabidol-related biotechnology, and (b) the right of the
Real Estate Committee to veto any decision of the Board of Directors controlled by the IXB Persons in taking any action set forth
in section (a) of this section.

 

3. Restrictive Covenants.
All Proprietary Information created, discovered, or developed by, or otherwise made known to, AHIT or IXB, at the time of closing
or following the closing of the SEA shall be the sole property of AHIT and IXB, as a wholly-owned subsidiary of AHIT, and its assigns.
Following the closing of the SEA, IXB, as a wholly-owned subsidiary of AHIT under the control of the IXB Persons, and the IXB Persons,
individually and collectively, or their respective assigns, designees or agents will not, without the Real Estate Committee’s
express written consent, engage, directly or indirectly, in any employment or activity in any competitive business, other than
for AHIT and IXB, and will not circumvent AHIT or IXB associated with any business opportunity in cannabidol-related biotechnology.

 

In the event of the
termination of the IXB Person’s employment or position on the Board of Directors for any reason, or disassociation by
the IXB Person from IXB or AHIT (a/the “Disassociated IXB Person”), and for five (5) years thereafter, the
Disassociated IXB Person agrees to the following provisions and restrictive covenants:

 

    	-2- 

    	 

    

 

(a) The Disassociated
IXB Person will deliver to AHIT and IXB all documents and data of any nature pertaining to his work with AHIT and IXB. The Disassociated
IXB Person will not take with him any documents or data of any description, or any reproduction of any description, containing
or pertaining to any Proprietary Information created, discovered or developed by, or made known to, the Disassociated IXB Person
during the period of his affiliation with AHIT or IXB.

 

(b) The Disassociated
IXB Person agrees not to solicit or in any manner encourage IXB Persons, actual customers, prospective customers or agents servicing
AHIT or IXB to leave their employ or transition business in any manner from AHIT or IXB, and, further, during such period, the
IXB Person will not offer employment to, or cause employment to be offered to, any person who is employed by AHIT or IXB at any
time during the six months before the termination of the Disassociated IXB Person’s affiliation with AHIT or IXB.

 

(c) The Disassociated
IXB Person will promptly disclose to the AHIT and IXB, or any persons designated by them, all improvements, inventions, formulae,
computer software processes, techniques, know-how, and data (collectively, “Inventions”), whether or not patentable,
made or conceived or reduced to practice as learned by the Disassociated IXB Person, either alone or jointly with others, during
the period of the Disassociated IXB Person’s affiliation with IXB or AHIT (whether during or after normal business hours),
which are related to or are useful in the development and marketing of the products of IXB or AHIT, or which result from tasks
assigned to the Disassociated IXB Person by IXB or AHIT, or result from the use of the premises, equipment, or materials owned,
leased, or contracted for by IXB or AHIT.

 

(d) All Inventions
shall be the sole property of IXB or AHIT, as the case may be, and its assigns, and IXB or AHIT, and its assigns, shall be the
sole owner of all patents, copyrights, and other rights in connection with the Inventions. The Disassociated IXB Person agrees
to assign to IXB or AHIT, as the case may be, any rights he may have or acquire in all Inventions. As to all Inventions, the Disassociated
IXB Person will assist IXB and AHIT, in every proper way (but at IXB’s or AHIT’s expense) to obtain and from time to
time enforce patents and inventions in any and all countries, and to that end, the Disassociated IXB Person will execute all documents
for use in applying for and obtaining such patents thereon and enforcing same, as IXB and AHIT may desire, together with any assignment
thereof to IXB or AHIT, as the case may be, or persons designated by it. The Disassociated IXB Person’s obligation to assist
IXB and AHIT in obtaining and enforcing patents for Inventions in any and all countries shall continue beyond the termination of
the Disassociated IXB Person’s association with IXB or AHIT, but IXB or AHIT shall compensate the Disassociated IXB Person
at a reasonable rate after such disassociation for time actually spent by the Disassociated IXB Person at IXB’s or AHIT’s
request of such assistance.

 

(e) The IXB
Person and a Disassociated IXB Person agrees that he will not in any way, directly or indirectly, (i) solicit, induce,
influence, or attempt to solicit, induce, or influence any customers, clients, or joint venturers of IXB or AHIT; (ii)
solicit, induce, influence, or attempt to solicit, induce, or influence for any business endeavor any IXB Person, or
stockholder, partner, lessor, or supplier of IXB or AHIT to discontinue or reduce or modify the extent of their relationship
with IXB or AHIT; or (iii) otherwise divert or attempt to divert from the Company any business whatsoever or interfere with
any business relationship between IXB and/or AHIT and any other person. If any portion of this noncompetition covenant is
deemed not to be enforceable by a court of competent jurisdiction because it is deemed overly broad in terms of time or the
geographic area covered, this noncompetition covenant shall not be void but shall be modified to extend through a reasonable
time period and/or geographic area.

 

    	-3- 

    	 

    

 

4. Remedies for Breach.
In addition to any other rights and remedies available to IXB or AHIT for any breach by an IXB Person of his duties or obligations
under this Agreement, IXB or AHIT shall be entitled to enforcement of any duty or obligation under this Agreement by court injunction
in a court of competent jurisdiction and in accordance with the laws of the jurisdiction chosen unilaterally by the Company, or
pursuant to the arbitration provision under Section 7, below.

 

5. Severability.
If any provision of this Agreement is declared invalid, illegal, or unenforceable, the provision shall be severed and all remaining
provisions shall continue in full force and effect. This Agreement shall be binding on the IXB Person, and his or her heirs, executors,
assigns, and administrators and shall inure to the benefit of the Company, its successors and assigns.

 

6. Jurisdiction of Disputes
and Applicable Law. This Agreement has been negotiated, executed, and delivered in the State of Arizona, and shall be governed
in all aspects by the laws of the jurisdiction of the State of Arizona. Subject to Section 7, below, any and all disputes, controversies,
or claims arising out of or in connection with or relating to this Agreement, The Parties agree that any dispute arising out of,
or relating in any way to, this Agreement that has not been resolved by good-faith negotiations will be finally submitted to binding
arbitration through the American Arbitration Association.  The arbitration and shall be governed by the then-current AAA Commercial
Arbitration Code and will be conducted by a single arbitrator.  The arbitration will comply with all aspects of the Federal
Arbitration Act, and judgment on the award rendered by the arbitrator (if any) may be entered by any court of proper jurisdiction.
The place of arbitration will be Phoenix, Arizona. The arbitrators are not empowered to award damages in excess of any lawful limitations
on damages provided in this agreement.  The substantive law governing any dispute will be the laws of the State of Arizona.
The statute of limitations of the State of Arizona applicable to the commencement of the lawsuit will apply to the commencement
of an arbitration under this section. Cost of arbitration shall be shared equally by the parties, provided that each party shall
pay for and bear the cost of his or her own experts, evidence, and attorney fees. Judgment on the award rendered by the arbitrator
may be entered in any court having jurisdiction to do so.

 

7. Equitable Relief.
Because IXB and AHIT do not have an adequate remedy at law to protect its business from the breach of an IXB Person’s covenants
under this Agreement, IXB or AHIT, as the case may be, shall be entitled to injunctive relief, in addition to such other remedies
and relief that would, in the event of a breach of the provisions of this Agreement, be available to IXB or AHIT. Each IXB Person
agrees to submit to the jurisdiction of the court in which IXB or AHIT seeks such equitable relief provided that such jurisdiction
is reasonably accessible to the IXB Person. In the event of such a breach, in addition to any other remedies, IXB or AHIT, as the
case may be, shall be entitled to receive from the IXB Person in breach of this Agreement payment of, or reimbursement for, its
reasonable attorney fees and disbursements incurred in enforcing any such provision.

    	-4- 

    	 

    

 

8. Royalty Payments
as Liquidated Damages. The IXB Persons agree that IXB or AHIT, as the case may be, may elect a remedy of liquidated damages
equal to the amount of any and all gross sales or revenues earned by an IXB Person in breach of this Agreement for the benefit
of any future employer or principal under an independent contract agreement using the Proprietary Information or Inventions, or
any derivatives thereof (hereinafter referred to as “Royalties”). The IXB Persons agree to produce this Agreement to
any future employer or principal in order to put them on notice of his or her duties and obligations under this Agreement and IXB’s
and/or AHIT’s rights to Royalties, and the IXB Person agrees to provide IXB and AHIT a monthly accounting of Royalties. The
IXB Person agrees that payments of any Royalties are due within fourteen (14) days upon receipt by the IXB Person or the IXB Person’s
future employer or principal. The IXB Person further

agrees that IXB or AHIT may produce this Agreement
to any payor or customer of the IXB Person’s future employer or principal requesting that payments of any Royalties be made
directly to IXB or AHIT.

 

9. Press Releases.
Other than any required filings under the federal securities laws, none of the parties hereto will, without first obtaining the
approval of the other, make any public announcement, directly or indirectly, regarding this Agreement, nor the nature of the transaction
contemplated by this Agreement, to any person except as required by law or regulatory bodies and other than to the respective principals
or other representatives of the parties, each of whom shall be similarly bound by such confidentiality obligations. If any such
press release or public announcement is so required by either party (except in the case of any disclosure required under the federal
securities laws to be made in a filing with the SEC), the disclosing party shall consult with the other parties prior to making
such disclosure, and the parties shall use all reasonable efforts, acting in good faith, to agree upon a text for such disclosure
which is satisfactory to each of the parties.

 

10. Expenses. Regardless
of whether this Agreement is executed, all legal and other costs and expenses incurred in connection with this Agreement and the
transactions contemplated hereby shall be paid by the party hereto incurring such costs and expenses.

 

11. Entire Agreement.
This Agreement constitutes the entire agreement between the parties hereto and supersedes all prior agreements and understandings,
both written and oral, with respect to the subject matter hereof.

 

12. Amendment. Any
term of this Agreement may be modified or amended only by an instrument in writing signed by each of the parties hereto.

 

13. Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which together
shall constitute one and the same instrument. Signatures on this Agreement may be communicated by facsimile transmission, emailed
PDFs, or other electronic means of communication and shall be binding upon the parties hereto so transmitting their signatures.
Counterparts with original signatures shall be provided to the other parties hereto following the applicable facsimile transmission;
provided that the failure to provide the original counterpart shall have no effect on the validity or the binding nature of this
Agreement.

    	-5- 

    	 

    

 

[SIGNATURES ON NEXT PAGE]

 

IN WITNESS WHEREOF, the
parties hereto have caused this Agreement to be duly executed and delivered as of the Closing defined in the SEA.

 

AMERICAN HOUSING INCOME TRUST, INC.

 

 

By: /s/ Sean Zarinegar

Sean Zarinegar

Chairman of the Board

Authorized by Board of
Directors

 

IX BIOTECHNOLOGY, INC.

 

By: /s/ Michael Ogburn

Michael Ogburn

President

Authorized by Board of
Directors

 

By: /s/ Michael Ogburn

Michael Ogburn

 

By: /s/ Joaquin Flores

Joaquin Flores

 

By: /s/ Brian Werner

Brian Werner

 

 

 

 

    	-6-Exhibit 10.1

 

SECOND AMENDMENT TO ACQUISITION
AGREEMENT

 

 

THIS SECOND
AMENDMENT TO ACQUISITION AGREEMENT (this “Amendment”), dated March 16, 2017, but made effective as of February
13, 2017 (the “Effective Date”), is by and among Maglenta Enterpises Inc., a company incorporated and existing
in the Republic of Seychelles (“Maglenta”), Champfremont Holding Ltd., a company incorporated and existing
in the Republic of Seychelles (“CHL”) (each of the foregoing individually, a “Seller” and,
collectively, “Sellers”); Polimore Capital Limited, a company incorporated and existing under the laws of Cyprus,
Brosword Holding Limited, a company incorporated and existing under the laws of Cyprus, and other companies listed under the caption
“Target Company” in Exhibit B to the Acquisition Agreement (as defined below) (each of the foregoing individually,
a "Target Company" and, collectively, the "Target Companies"); ТOT Group Russia LLC, a
limited liability company organized and existing under the laws of the Russian Federation, and/or its assignee, and TOT Group
Europe Ltd., a company organized and existing under the laws of England and Wales, and/or its assignee (each of the foregoing
individually, a “Purchaser” and, collectively, the "Purchasers"). Sellers, Purchasers and
Target Companies are referred to herein collectively as the “Parties.” 

 

RECITALS

 

 

WHEREAS,
on or about May 20, 2015, Sellers, Target Companies and Purchasers entered into that certain Acquisition Agreement (the “Acquisition
Agreement”) and Net Element, Inc., a Delaware corporation (the “Guarantor”), executed that certain
guaranty in connection with the Purchasers’ certain obligations under the Acquisition Agreement (the “Guaranty”).

 

WHEREAS,
on or about October 25, 2016 (but made effective as of October 21, 2016), the Sellers and the Guarantor entered into that certain
settlement agreement (the “Settlement Agreement”) in connection with Purchasers’ obligations under the
Acquisition Agreement.

 

WHEREAS,
on or about October 25, 2016, the Sellers, Target Companies and Purchasers entered into that certain amendment to Acquisition Agreement
(the “First Amendment”). The Acquisition Agreement, as amended by the First Amendment, shall be referred to
herein as the “Amended Acquisition Agreement.” Capitalized terms used but not defined herein shall have the
meanings ascribed to such terms in the Amended Acquisition Agreement.

 

WHEREAS
the Parties would like to reconcile certain obligations set forth in the Amended Acquisition Agreement and amend certain terms
of the Amended Acquisition Agreement, as more particularly set forth herein. 

 

NOW, THEREFORE,
in consideration of the mutual covenants contained herein, the Parties hereby agree that the Amended Acquisition Agreement shall
be further amended as follows: 

 

1.                 
Recitals. All of the recitals contained herein are true and correct and are incorporated
herein by this reference. 

 

2.                 
Amendment. Notwithstanding prior correspondence of the Parties and their respective
representatives, the Parties have reconciled the amounts, the calculations, the methodology, the procedures of review and approval,
the process and dates of payments in cash and issuances of Consideration Shares in respect to the Deferred Consideration (specifically,
the second, third, fourth, fifth Installments and Extra Payment) as set forth in Annex 1 to this Amendment. Accordingly,
the Parties hereby agree that the first paragraph of Section 2.7 and Sub-Sections 2.7.1 through and inclusive of 2.7.5 of the Amended
Acquisition Agreement are hereby modified and amended in their entirety to reflect the terms set forth in Annex 1 to this
Amendment. None of the procedures and/or remedies shall be applicable with respect to any Party or Guarantor in connection with
any performance or non- performance, delay or failure to reconcile the Deferred Consideration pursuant to the first paragraph of
Section 2.7 and Sub-Sections 2.7.1 through and inclusive of 2.7.5 of the Amended Acquisition Agreement prior to the Effective Date.
Notwithstanding anything to the contrary set forth in this Section 2, nothing herein shall modify the Parties’ obligations
under the Settlement Agreement and the First Amendment, including but not limited to, the Purchasers’ and Guarantor’s
payment obligations thereunder.

 

    	 	1	 

     

    

 

3.                 
This Amendment (including Annex 1 hereto) is legally binding on each of the Parties.
In consideration of the mutual covenants and conditions contained herein this Amendment supersedes all previous correspondence
and negotiations between Parties regarding the Deferred Consideration. 

 

4.                 
Except as expressly amended and modified by this Amendment, the Amended Acquisition Agreement
shall continue in full forth and effect. 

 

5.                 
This Amendment shall be governed by and construed in accordance with the laws of the State
of New York, without regard to principles of conflicts of law thereof. Each Party hereby irrevocably submits to the jurisdiction
of the courts of the State of New York, sitting in New York County, and the courts of the United States for the Southern District
of New York. Each Party irrevocably waives, to the fullest extent permitted by law, any objection which it may now or hereafter
have to the laying of the venue of any such suit, action or proceeding brought in any such court, any claim that any such suit,
action or proceeding brought in such a court has been brought in an inconvenient forum and the right to object, with respect to
any such suit, action or proceeding brought in any such court, that such court does not have jurisdiction over such Party. In
any such suit, action or proceeding, each Party waives, to the fullest extent it may effectively do so, personal service of any
summons, complaint or other process and agrees that the service thereof may be made by certified or registered mail, addressed
to such Party at its address as set forth in the Amended Acquisition Agreement. 

 

6.                 
This Amendment may be executed in counterparts, each of which shall be an original, but all
of which together shall constitute one and the same agreement. The exchange of copies of this Amendment and of signature pages
by facsimile transmission, pdf or other electronic means shall constitute effective execution and delivery of this Amendment as
to the parties and may be used in lieu of the original Amendment for all purposes (and such signatures of the parties transmitted
by facsimile, pdf or other electronic means shall be deemed to be their original signatures for all purposes).

 

[Signatures start on next page.]

 

    	 	2	 

     

    

 

 

IN WITNESS
WHEREOF, each of the Parties has duly executed this Amendment as of the Effective Date.

 

 

SELLERS:

  

 

MAGLENTA ENTERPRISES INC.

 

By:  /s/ Evaline Sophie Joubert                                        

Name: Evaline Sophie Joubert

Title: Director

 

 

CHAMPFREMONT HOLDING LTD

 

By:  /s/ Nicos Hadjinicolaou                                             

Name: Nicos Hadjinicolaou

Title: Director

  

  

TARGET COMPANIES:

 

 

POLIMORE CAPITAL LIMITED

 

By:  /s/ Avraam Marangos                                                

Name: Avraam Marangos

Title: Director

 

 

BROSWORD HOLDING LIMITED

 

By: /s/ Avraam Marangos                                                

Name: Avraam Marangos

Title: Director

 

 

INNOVATIVE PAYMENT TECHNOLOGIES LLC

 

By: /s/ Madina Khandzharova                                        

Name: Madina Khandzharova

Title: General Director

 

 

 

 

 

[Signatures continue on next page.]

 

    	 	3	 

     

    

 

 

PAYONLINE SYSTEM LLC

 

By: /s/ Marat Abasaliev                                 

Name: Marat Abasaliev

Title: General Director

 

 

PURCHASERS:

 

 

TOT GROUP RUSSIA, LLC

 

By:_/s/ Konstantin Zaripov                          

Name: Konstantin Zaripov

Title: General Director

 

TOT GROUP EUROPE LTD

By:_/s/ Konstantin Zaripov                          

Name: Konstantin Zaripov

Title: Managing Director

 

 

ACKNOWLEDGED AND AGREED TO BY THE
GUARANTOR FOR PURPOSES OF THE GUARANTY:

 

  

NET ELEMENT, INC.

 

  

By:  /s/ Oleg Firer                                        

Name:  Oleg Firer                                        

Title:  CEO                                                    

 

 

 

 

    	 	4	 

     

    

 

ANNEX 1

 

 

1.                     
The amount of the second Installment is calculated and reconciled by the Parties, and accordingly
is defined for all purposes of the Amended Acquisition Agreement as One Hundred Fifteen Thousand One Hundred Ninety Six and 20/100
US dollars (US $115,196.20). Purchasers previously paid and Sellers previously received US $72,360.40 in cash and US $72,360.40
in Consideration Shares as payment for the second Installment, resulting in US $29,524.60 overpayment to the Purchasers for the
second Installment. 

 

2.                     
The amount of the third Installment is calculated and reconciled by the Parties, and accordingly
is defined for all purposes of the Amended Acquisition Agreement as Ninety-Three Thousand Seven Hundred Thirty-One and 32/100
US dollars (US $93,731.32). Purchasers previously paid and Sellers previously received US $61,735.57 in cash and US $61,735.57
in Consideration Shares as payment for the third Installment, resulting in US $29,739.82 overpayment to the Purchasers for the
third Installment. 

 

3.                     
The amount of the fourth Installment is calculated and reconciled by the Parties, and accordingly
is defined for all purposes of the Amended Acquisition Agreement as One Hundred Sixty Thousand Nine Hundred Eighty- Seven and
94/100 US dollars (US $160,987.94). 

 

4.                     
The amount of the fifth Installment is calculated and reconciled by the Parties, and accordingly
is defined for all purposes of the Amended Acquisition Agreement as One Hundred Fourteen Thousand Five Hundred Ninety-Two and
72/100 US dollars (US $114,592.72). 

 

5.                     
The amount of the Extra Payment is calculated and reconciled by the Parties, and accordingly
is defined for all purposes of the Amended Acquisition Agreement as Eight Hundred Forty-Eight and 43/100 US dollars (US $848.43). 

 

6.                     
The aggregate amount for the Deferred Consideration (specifically, the second, third, fourth,
fifth Installments and Extra Payment combined) is calculated and reconciled by the Parties, and accordingly is defined for all
purposes of the Amended Acquisition Agreement as Four Hundred Eighty-Five Thousand Three Hundred Fifty-Six and 61/100 US dollars
(US $485,356.61). 

 

7.                     
As set in paragraphs 1 and 2 this Annex 1, the Purchasers previously paid the Sellers Two
Hundred Sixty-Eight Thousand One Hundred Ninety-One and 94/100 US dollars (US $268,191.94). 

 

8.                     
Accordingly, the remaining aggregate amount to be payable by the Purchaser to the Sellers
pursuant to the Amended Acquisition Agreement (as amended by this Amendment, including this Annex 1) for the Deferred Consideration
(specifically, the second, third, fourth, fifth Installments and Extra Payment combined) is calculated and reconciled by the Parties,
and accordingly is defined for all purposes of the Amended Acquisition Agreement as Two Hundred Seventeen Thousand One Hundred
Sixty-Six US dollars (US $217,166) (the “Final Amount”). 

 

9.                      The Final Amount shall be comprised of two (2) components: (i) cash in the amount of 50% of
Final Amount and (ii) Consideration Shares with a value equal to 50% of the Final amount (the number of such Consideration Shares
shall be determined based on the closing price per one (1) share of NETE Stock reported on The NASDAQ Capital Market on the Effective
Date (specifically, February 13, 2017). For avoidance of doubt, this Amendment shall be executed and delivered by the Parties and
dated only on the date when The NASDAQ Capital Market is open for trading.

 

    	 	5	 

     

    

 

 

10.                  
The Final Amount shall be paid (in cash and in Consideration Shares as determined and provided
in paragraph 9 of this Annex 1) by the Purchasers to the Sellers, and the Sellers will accept such Final Amount as full and complete
satisfaction and settlement of the Deferred Consideration (specifically, the second, third, fourth, fifth Installments and Extra
Payment), in accordance with the following schedule:

 

The cash in the amount of 50%
of Final Amount shall be paid within five (5) Business Days after Purchasers receive signed by Sellers counterpart of this Amendment
according to Section 6 of this Amendment. The Consideration Shares, specifically 130,823 shares based on the closing price per
(1) share of NETE Stock reported on The NASDAQ Capital Market on the Effective Date, shall be issued within forty-five (45) calendar
days after Purchasers receive signed by Sellers counterpart of this Amendment according to Section 6 of this Amendment, however,
that the Consideration Shares in the amount as determined and provided in paragraph 9 of this Annex 1 shall be delivered to the
Sellers after the applicable securities laws and the Nasdaq formalities and the transfer agent formalities are complied with and
the securities law opinion with respect to the issuance of the shares is obtained by the Guarantor.

 

11.                  
Upon payment of the Final Amount to the Sellers (specifically, by a wire transfer US $108,583
to the bank account designated in writing by the Sellers and by the issuance of 130,823 Consideration Shares in the name of the
Sellers (divided between the Sellers as per such Sellers’ written instructions), (i) the entire Deferred Consideration (specifically,
the second, third, fourth, fifth Installments and Extra Payment) shall be paid in full and (ii) none of the Parties shall have,
and each Party hereby irrevocably releases, any and all rights, obligations, claims and/or liabilities related to the Deferred
Consideration (specifically, the second, third, fourth, fifth Installments and Extra Payment).

 

 

    	 	6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}]]